| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.92B | 69.96B | 45.90B | 39.46B | 39.51B | 38.12B |
| Gross Profit | 21.46B | 22.25B | 19.94B | 19.53B | 19.73B | 19.66B |
| EBITDA | 4.01B | 2.80B | 3.32B | 3.29B | 3.25B | 3.10B |
| Net Income | 1.49B | 1.79B | 1.38B | 1.30B | 1.15B | 1.49B |
Balance Sheet | ||||||
| Total Assets | 68.00B | 68.84B | 66.49B | 50.64B | 50.21B | 56.88B |
| Cash, Cash Equivalents and Short-Term Investments | 1.69B | 1.33B | 1.71B | 1.58B | 1.80B | 2.90B |
| Total Debt | 15.50B | 12.93B | 14.91B | 24.00M | 39.00M | 70.00M |
| Total Liabilities | 28.78B | 27.77B | 27.55B | 12.04B | 11.99B | 13.96B |
| Stockholders Equity | 39.22B | 41.07B | 38.94B | 38.60B | 38.21B | 42.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 466.00M | 2.26B | 1.79B | 2.26B | 1.44B |
| Operating Cash Flow | 0.00 | 1.10B | 3.02B | 2.67B | 3.10B | 1.87B |
| Investing Cash Flow | 0.00 | 2.27B | -10.54B | -1.10B | -2.37B | 106.00M |
| Financing Cash Flow | 0.00 | -3.75B | 7.65B | -1.79B | -1.83B | -1.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥23.49T | 40.16 | 19.84% | 0.90% | 11.25% | 16.84% | |
73 Outperform | ¥719.28B | 20.92 | 8.48% | 2.02% | 5.20% | 6.54% | |
73 Outperform | ¥67.53B | 10.90 | ― | 2.73% | 9.07% | 42.66% | |
72 Outperform | ¥41.05B | -29.01 | ― | 3.62% | -3.00% | -23.04% | |
71 Outperform | ¥261.14B | 19.34 | ― | 1.46% | 12.93% | 32.83% | |
65 Neutral | ¥38.76B | 18.08 | ― | 4.71% | 52.42% | 30.07% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |